Published in Am J Clin Pathol on February 01, 1991
Antigen localization and migration in immunity and tolerance. N Engl J Med (1998) 3.71
The lost chord: microchimerism and allograft survival. Immunol Today (1996) 2.81
Transplantation milestones. Viewed with one- and two-way paradigms of tolerance. JAMA (1995) 2.20
Transplantation tolerance from a historical perspective. Nat Rev Immunol (2001) 2.04
Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells (1995) 1.83
Transplantation tolerance, microchimerism, and the two-way paradigm. Theor Med Bioeth (1998) 1.67
Chimerism and tolerance in transplantation. Proc Natl Acad Sci U S A (2004) 1.07
Acquired immunologic tolerance: with particular reference to transplantation. Immunol Res (2007) 0.97
The unfinished legacy of liver transplantation: emphasis on immunology. Hepatology (2006) 0.93
Explanation for loss of the HLA matching effect. Transplant Proc (1995) 0.91
History of clinical transplantation. World J Surg (2000) 0.91
Liver transplants contribute to their own success. Nat Med (1996) 0.89
The future of transplantation: with particular reference to chimerism and xenotransplantation. Transplant Proc (1997) 0.83
Organ transplantation: a practical triumph and epistemologic collapse. Proc Am Philos Soc (2003) 0.82
Back to the future. Transplantation (2005) 0.79
The dichotomous functions of passenger leukocytes in solid-organ transplantation. Adv Nephrol Necker Hosp (1995) 0.79
The mystique of organ transplantation. J Am Coll Surg (2005) 0.78
The two-way paradigm of transplantation immunology. Clin Immunol Immunopathol (1996) 0.78
Immunity and tolerance are related, and governed by antigen migration and localization. Transplant Proc (1999) 0.77
The current status of hepatic transplantation at the University of Pittsburgh. Clin Transpl (1995) 0.76
Chimerism after organ transplantation. Curr Opin Nephrol Hypertens (1997) 0.76
The birth of clinical organ transplantation. J Am Coll Surg (2001) 0.76
The origin of clinical organ transplantation revisited. JAMA (2009) 0.76
[Allograft "acceptance" and tolerance: a new concept]. Bull Acad Natl Med (1998) 0.75
Anthony Cerami Award in Translational Medicine: A Journey in Science: The Birth of Organ Transplantation with Particular Reference to Alloengraftment Mechanisms. Mol Med (2015) 0.75
Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients. Transplant Proc (1997) 0.75
The bidirectional paradigm of transplant immunology. Ann N Y Acad Sci (1995) 0.75
The basis of allograft acceptance. Forum (Genova) (1997) 0.75
Current perspectives of transplantation immunology via the intestine. Transplant Proc (1996) 0.75
1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant (1995) 24.01
Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation (1974) 10.91
Continual reassessment method: a practical design for phase 1 clinical trials in cancer. Biometrics (1990) 10.19
Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med (1995) 10.04
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med (1980) 9.64
The continuing HIV epidemic among men who have sex with men. Am J Public Health (2001) 5.56
Structure of mouse metallothionein-I gene and its mRNA. Nature (1981) 5.06
Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II. Nature (1992) 4.63
Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1989) 4.45
Transcriptional regulation of the mouse metallothionein-I gene by heavy metals. J Biol Chem (1981) 4.20
Bone-marrow transplantation (second of two parts). N Engl J Med (1975) 4.11
A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet (1979) 4.01
Why outcome of cardiopulmonary resuscitation in general wards is poor. Lancet (1982) 3.71
A case-management system for coronary risk factor modification after acute myocardial infarction. Ann Intern Med (1994) 3.61
Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med (1979) 3.59
Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis (1986) 3.31
A practical approach for quantitating specific mRNAs by solution hybridization. Anal Biochem (1983) 3.30
Monoclonal antibodies to cytomegalovirus: rapid identification of clinical isolates and preliminary use in diagnosis of cytomegalovirus pneumonia. Infect Immun (1982) 3.22
Isolation and characterization of the mouse metallothionein-I gene. Proc Natl Acad Sci U S A (1980) 3.17
Iron Metabolism. Heme Synthesis in Vitro by Immature Erythrocytes. Science (1949) 3.14
Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood (1981) 3.03
Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc (1974) 2.95
Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med (1990) 2.66
Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med (1981) 2.61
Percutaneous transluminal coronary angioplasty: report from the Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol (1982) 2.54
Nobel laureates' letter to President Bush. Washington Post (2001) 2.43
Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. Rev Infect Dis (1983) 2.39
One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood (1977) 2.36
Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS). Circulation (1981) 2.36
Risk factors for transmission of Mycobacterium tuberculosis in a primary school outbreak: lack of racial difference in susceptibility to infection. Am J Epidemiol (1994) 2.34
A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood (1990) 2.32
Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood (1976) 2.29
Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol (1988) 2.24
Direct evidence for a bone marrow origin of the alveolar macrophage in man. Science (1976) 2.23
Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology (1984) 2.19
Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. Lancet (1972) 2.13
A prospective analysis interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts. J Infect Dis (1977) 2.10
A test of the National Death Index using the Coronary Artery Surgery Study (CASS). Control Clin Trials (1985) 2.06
Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature (1987) 2.04
Induction of mouse metallothionein-I mRNA by bacterial endotoxin is independent of metals and glucocorticoid hormones. Proc Natl Acad Sci U S A (1984) 2.03
Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med (1983) 2.03
Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med (1986) 1.99
Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood (1994) 1.98
Reiter's syndrome. Evaluation of preliminary criteria for definite disease. Arthritis Rheum (1981) 1.97
Infection due to Corynebacterium species in marrow transplant patients. Ann Intern Med (1979) 1.94
Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol (1990) 1.91
Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N Engl J Med (1983) 1.89
The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients. Gastroenterology (1980) 1.88
Circulating Borrelia burgdorferi in patients with acute Lyme disease: results of blood cultures and serum DNA analysis. J Infect Dis (1993) 1.88
MT-III, a brain-specific member of the metallothionein gene family. Proc Natl Acad Sci U S A (1992) 1.84
Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med (1993) 1.84
A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood (1979) 1.83
Technique for human marrow grafting. Blood (1970) 1.83
Cytomegalovirus pneumonia after human marrow transplantation. Ann Intern Med (1975) 1.80
Leukaemic transformation of engrafted human marrow cells in vivo. Lancet (1971) 1.79
Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. N Engl J Med (1988) 1.77
Allogeneic marrow grafting for treatment of aplastic anemia. Blood (1974) 1.76
The neuropathological and behavioral consequences of intraspinal microglial/macrophage activation. J Neuropathol Exp Neurol (2002) 1.75
Bone marrow grafts and tolerance. Nature (1986) 1.74
Predictive value of pulmonary function tests before marrow transplantation. Chest (1992) 1.73
Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol (1988) 1.72
Marrow transplantation for thalassaemia. Lancet (1982) 1.71
Psychosocial therapies in diabetes: report of the Psychosocial Therapies Working Group. Diabetes Care (2001) 1.67
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation. Blood (1997) 1.64
Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas. Blood (1987) 1.63
Sucrose-regulated expression of a chimeric potato tuber gene in leaves of transgenic tobacco plants. Plant Mol Biol (1989) 1.61
Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet (1984) 1.60
Myocardial necrosis from direct current countershock. Effect of paddle electrode size and time interval between discharges. Circulation (1974) 1.58
The skin biopsy in the diagnosis of acute graft-versus-host disease in man. Am J Pathol (1977) 1.58
Hemophilia: role of organ homografts. Science (1969) 1.56
Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury. N Engl J Med (1981) 1.56
Gastrointestinal graft-versus-host disease in man. A clinicopathologic study of the rectal biopsy. Am J Surg Pathol (1979) 1.55
Linkage between the gene (or genes) controlling synthesis of the fourth component of complement and the major histocompatibility complex. N Engl J Med (1977) 1.55
Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro. J Exp Med (2001) 1.50
Interstitial pneumonia and cytomegalovirus infection as complications of human marrow transplantation. Transplantation (1973) 1.48
Bone marrow transplantation in acute leukemia. Cancer Res (1965) 1.46
Acute hepatic coma treated by cross-circulation or exchange transfusion. N Engl J Med (1967) 1.46
Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med (1983) 1.44
Rapid diagnosis of cytomegaloviral pneumonia by tissue immunofluorescence with a murine monoclonal antibody. J Infect Dis (1985) 1.44
Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med (1979) 1.44
Genetic counseling for beta-thalassemia trait following health screening in a health maintenance organization: comparison of programmed and conventional counseling. Am J Hum Genet (1981) 1.44
The effectiveness of family interventions in people with diabetes mellitus: a systematic review. Diabet Med (2005) 1.43
Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med (1986) 1.41
Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia. Bone Marrow Transplant (1992) 1.40
B-scan ultrasonic measurement of the lumbar spinal canal as a predictor of industrial back pain complaints and extended work loss. J Occup Med (1993) 1.40
The value of Pneumocystis carinii antibody and antigen detection for diagnosis of Pneumocystis carinii pneumonia after marrow transplantation. Am Rev Respir Dis (1979) 1.40
T-cell subpopulations identified by monoclonal antibodies after human marrow transplantation. I. Helper-inducer and cytotoxic-suppressor subsets. Blood (1982) 1.39
Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood (1988) 1.39
Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: effects on knowledge and mood. Am J Hum Genet (1979) 1.39
'Locked-in syndrome' for 27 years following a viral illness: clinical and pathologic findings. Neurology (1991) 1.39
Aplastic anaemia treated by marrow transplantation. Lancet (1972) 1.39
Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis. N Engl J Med (1982) 1.38
Osteoarthritis of the hip and osteoporosis of the proximal femur. Ann Rheum Dis (1991) 1.38
Induction of metallothionein-I mRNA in cultured cells by heavy metals and iodoacetate: evidence for gratuitous inducers. Mol Cell Biol (1984) 1.37